Haryana Health Minister Anil Vij tests positive for COVID despite taking `COVAXIN' shot
Interestingly, health minister had volunteered to take a shot of Hyderabad based Bharat Biotech's `COVAXIN' on November 20
By Newsmeter Network Published on 5 Dec 2020 7:01 AM GMTHyderabad: Haryana Health Minister Anil Vij, who took Bharat Biotech's `COVAXIN' shot on November 20, has tested positive for COVID 19 on Saturday.
"I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact with me are advised to get themselves tested for corona," he tweeted.
I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact to me are advised to get themselves tested for corona.
ā ANIL VIJ MINISTER HARYANA (@anilvijminister) December 5, 2020
Interestingly, health minister had volunteered to take a shot of Hyderabad based Bharat Biotech's `COVAXIN' on November 20, as part of the trial of the third phase of the vaccine.
#WATCH Haryana Health Minister Anil Vij being administered a trial dose of #Covaxin, at a hospital in Ambala.
ā ANI (@ANI) November 20, 2020
He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today. pic.twitter.com/xKuXWLeFAB
Covaxin, a potential vaccine against the novel coronavirus, is being developed indigenously by Bharat Biotech along with the Indian Council of Medical Research (ICMR).
Health Minister had earlier announced that he will be the first volunteer in his state for the anti-Covid vaccine.
Trial for third phase of Covaxin a coronavirus vaccine product of Bhart Biotech to start in Haryana on 20th November. I have offered myself as first volunteer to get vaccinated .
ā ANIL VIJ MINISTER HARYANA (@anilvijminister) November 18, 2020
The vaccine maker had earlier announced that it successfully completed an interim analysis of Phase 1 and 2 trials and is working on Phase 3 trials.
Bharat Biotech issued a statement after the minister tested positive. "Covaxin clinical trials are based on a 2 dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose. Covaxin has been designed to be efficacious when subjects receive both doses and post the 14 day period after the second dose," said Bharat Biotech in its statement.
Prime Minister Narendra Modi has visited the Genome Valley in the city on November 29 where the COVID vaccine is being developed